Cytokine profile in community-acquired pneumonia in children

Community-acquired pneumonia (CAP) is one of the most common acute infectious diseases. To date, the incidence of CAP among children was decreased significantly worldwide, mainly due to increasing use of effective preventive measures. Nevertheless, CAP remains a common cause of childhood morbidity a...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Iziurova, A. Yu. Savochkina, A. N. Uzunova, D. Yu. Nokhrin
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2022-11-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/2538
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839571393500413952
author N. V. Iziurova
A. Yu. Savochkina
A. N. Uzunova
D. Yu. Nokhrin
author_facet N. V. Iziurova
A. Yu. Savochkina
A. N. Uzunova
D. Yu. Nokhrin
author_sort N. V. Iziurova
collection DOAJ
description Community-acquired pneumonia (CAP) is one of the most common acute infectious diseases. To date, the incidence of CAP among children was decreased significantly worldwide, mainly due to increasing use of effective preventive measures. Nevertheless, CAP remains a common cause of childhood morbidity and mortality. Pneumonia may develop at any age, but most often it occurs in young children, who are more likely to have a more severe course of pneumonia. Currently, early diagnosis and prognosis of the disease severity in children is an urgent issue. It was found that, in most cases, a panel of conventional biomarkers, including the number of leukocytes, procalcitonin, CRP is not sufficient for the diagnosis of pediatric CAP. There is a demand for new biological markers which, along with clinical evaluation, may significantly improve diagnostics and management of CAP in children, thus reducing the risk of adverse outcomes associated with this disease. Such markers could be found among the cytokines, which are active participants in the CAP pathogenesis. The aim of this study was to determine the level of several cytokines in blood serum of children with CAP and to assess changes in the cytokine profile depending on the patient’s age and severity of the disease. The study included 117 children aged 1 to 18 years with a diagnosis of CAP confirmed by X-ray examination. The comparison group included 28 healthy children who did not have CAP or other signs of acute respiratory viral infection at the time of examination, being free of any chronic pathology requiring outpatient observation. A number of cytokines were determined quantitatively in blood serum, i.e., IL-1β, IFNγ, IL-2, IL-4, IL-6, IL-10, TNFα, IFNλ2 (IL-28A), IFNλ3 (IL-28B), IL-8, MCP-1, IL-17AF, GM-CSF using test systems based on the “sandwich” method of solid-phase ELISA using peroxidase labeling. As a result, it was found that the content of IL-6, IL-17AF, IL-1β, IFNγ, MCP-1, IFNλ2 (IL-28A), IFNλ3 (IL-28B), GM-CSF was significantly higher in the group of children with severe community-acquired pneumonia. The levels of certain cytokines, e.g., IL-6, IFNλ2 (IL-28A), IFNλ3 (IL-28B), GM-CSF varied depending on the age of patients, thus, probably, reflecting the degree of immune system activation in the children of different age groups.
format Article
id doaj-art-68ca7d3dbccd4edaa0d83bca8c4d7d77
institution Matheson Library
issn 1563-0625
2313-741X
language Russian
publishDate 2022-11-01
publisher St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
record_format Article
series Медицинская иммунология
spelling doaj-art-68ca7d3dbccd4edaa0d83bca8c4d7d772025-08-04T14:30:40ZrusSt. Petersburg branch of the Russian Association of Allergologists and Clinical ImmunologistsМедицинская иммунология1563-06252313-741X2022-11-0124594395410.15789/1563-0625-CPI-25381585Cytokine profile in community-acquired pneumonia in childrenN. V. Iziurova0A. Yu. Savochkina1A. N. Uzunova2D. Yu. Nokhrin3South Ural Medical State UniversitySouth Ural Medical State UniversitySouth Ural Medical State UniversityChelyabinsk State UniversityCommunity-acquired pneumonia (CAP) is one of the most common acute infectious diseases. To date, the incidence of CAP among children was decreased significantly worldwide, mainly due to increasing use of effective preventive measures. Nevertheless, CAP remains a common cause of childhood morbidity and mortality. Pneumonia may develop at any age, but most often it occurs in young children, who are more likely to have a more severe course of pneumonia. Currently, early diagnosis and prognosis of the disease severity in children is an urgent issue. It was found that, in most cases, a panel of conventional biomarkers, including the number of leukocytes, procalcitonin, CRP is not sufficient for the diagnosis of pediatric CAP. There is a demand for new biological markers which, along with clinical evaluation, may significantly improve diagnostics and management of CAP in children, thus reducing the risk of adverse outcomes associated with this disease. Such markers could be found among the cytokines, which are active participants in the CAP pathogenesis. The aim of this study was to determine the level of several cytokines in blood serum of children with CAP and to assess changes in the cytokine profile depending on the patient’s age and severity of the disease. The study included 117 children aged 1 to 18 years with a diagnosis of CAP confirmed by X-ray examination. The comparison group included 28 healthy children who did not have CAP or other signs of acute respiratory viral infection at the time of examination, being free of any chronic pathology requiring outpatient observation. A number of cytokines were determined quantitatively in blood serum, i.e., IL-1β, IFNγ, IL-2, IL-4, IL-6, IL-10, TNFα, IFNλ2 (IL-28A), IFNλ3 (IL-28B), IL-8, MCP-1, IL-17AF, GM-CSF using test systems based on the “sandwich” method of solid-phase ELISA using peroxidase labeling. As a result, it was found that the content of IL-6, IL-17AF, IL-1β, IFNγ, MCP-1, IFNλ2 (IL-28A), IFNλ3 (IL-28B), GM-CSF was significantly higher in the group of children with severe community-acquired pneumonia. The levels of certain cytokines, e.g., IL-6, IFNλ2 (IL-28A), IFNλ3 (IL-28B), GM-CSF varied depending on the age of patients, thus, probably, reflecting the degree of immune system activation in the children of different age groups.https://www.mimmun.ru/mimmun/article/view/2538community-acquired pneumoniasevere pneumoniachildrencytokinesinterferonspneumonia markers
spellingShingle N. V. Iziurova
A. Yu. Savochkina
A. N. Uzunova
D. Yu. Nokhrin
Cytokine profile in community-acquired pneumonia in children
Медицинская иммунология
community-acquired pneumonia
severe pneumonia
children
cytokines
interferons
pneumonia markers
title Cytokine profile in community-acquired pneumonia in children
title_full Cytokine profile in community-acquired pneumonia in children
title_fullStr Cytokine profile in community-acquired pneumonia in children
title_full_unstemmed Cytokine profile in community-acquired pneumonia in children
title_short Cytokine profile in community-acquired pneumonia in children
title_sort cytokine profile in community acquired pneumonia in children
topic community-acquired pneumonia
severe pneumonia
children
cytokines
interferons
pneumonia markers
url https://www.mimmun.ru/mimmun/article/view/2538
work_keys_str_mv AT nviziurova cytokineprofileincommunityacquiredpneumoniainchildren
AT ayusavochkina cytokineprofileincommunityacquiredpneumoniainchildren
AT anuzunova cytokineprofileincommunityacquiredpneumoniainchildren
AT dyunokhrin cytokineprofileincommunityacquiredpneumoniainchildren